Public primary and secondary skin cancer prevention, perceptions and knowledge: an international cross-sectional survey

Author:

Seité S.1,del Marmol V.2,Moyal D.1,Friedman A.J.34

Affiliation:

1. La Roche-Posay Dermatological Laboratories; Asnières France

2. Department of Dermatology; Hôpital Erasme; Université Libre de Bruxelles; Brussels Belgium

3. Department of Dermatology; George Washington School of Medicine and Health Sciences; Washington DC USA

4. Department of Physiology and Biophysics; Albert Einstein College of Medicine; Bronx NY USA

Funder

La Roche-Posay Dermatological Laboratories, Asnières, France

Publisher

Wiley

Subject

Infectious Diseases,Dermatology

Reference10 articles.

1. American Cancer Society Cancer facts and figures 2016 http://www.cancer.org/acs/groups/content/@research/documents/document/acspc-047079.pdf

2. Nivolumab and ipilimumab versus ipilimumab in untreated melanoma;Postow;N Engl J Med,2015

3. Combined nivolumab and ipilimumab or monotherapy in untreated melanoma;Larkin;N Engl J Med,2015

4. A landscape of driver mutations in melanoma;Hodis;Cell,2012

5. International trends in the incidence of malignant melanoma 1953-2008-are recent generations at higher or lower risk?;Erdmann;Int J Cancer,2013

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3